Figure 95c

A metal stent, with a detail of its mesh, is being coated with an immune suppressive drug called rapamycin in experiments aimed at preventing scar tissue (intimal proliferation) from forming in previously blocked coronary arteries treated with catheter ballon dilatation.

Reference:Cordis Corporation and Circulation Journal,Sousa,J.E.,MD,and others,Jan.,16,2001